Alaunos Therapeutics Inc - Asset Resilience Ratio

Latest as of December 2006: 5.27%

Alaunos Therapeutics Inc (TCRT) has an Asset Resilience Ratio of 5.27% as of December 2006. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$1.56 Million

Cash + Short-term Investments

Total Assets

$29.51 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2006–2006)

This chart shows how Alaunos Therapeutics Inc's Asset Resilience Ratio has changed over time. Check how strategically is Alaunos Therapeutics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Alaunos Therapeutics Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see TCRT company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$1.56 Million	5.27%
Total Liquid Assets	$1.56 Million	5.27%

Asset Resilience Insights

Limited Liquidity: Alaunos Therapeutics Inc maintains only 5.27% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Alaunos Therapeutics Inc Industry Peers by Asset Resilience Ratio

Compare Alaunos Therapeutics Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	5.66%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Abivax SA PA:ABVX	Biotechnology	2.34%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
REMEGEN CO. LTD YC 1 F:REG	Biotechnology	16.77%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Alaunos Therapeutics Inc (2006–2006)

The table below shows the annual Asset Resilience Ratio data for Alaunos Therapeutics Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2006-12-31	5.27%	$1.56 Million	$29.51 Million	--

pp = percentage points

About Alaunos Therapeutics Inc

NASDAQ:TCRT USA Biotechnology

Market Cap

$4.88 Million

Market Cap Rank

#28635 Global

#5796 in USA

Share Price

$2.03

Change (1 day)

-0.98%

52-Week Range

$1.77 - $4.36

All Time High

$2185.50